Kivman, L., Kraft, T., Rauser, J., Boxhammer, R., Hartle, S., Schwartz, B., . . . Barratt, J. WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN). Elsevier.
Chicago Style (17th ed.) CitationKivman, Lisa, et al. WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN). Elsevier.
MLA (9th ed.) CitationKivman, Lisa, et al. WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN). Elsevier.
Warning: These citations may not always be 100% accurate.